Overview
Headquarters
London, Greater London
Category
Next-generation oncology drug development
ConcR is an emerging predictive software platform built to combat cancer. ConcR combines cutting edge machine learning techniques with deep scientific understanding of tumour progression to accurately predict cancers evolution in response to treatment. This will enable clinicians to adapt treatments proactively, rather than reactively, to prevent treatment resistance and improve treatment efficacy through precision medicine. ConcR aims to: -Reduce treatment resistance -Cut cost of cancer treatment -Enable proactive treatment adaptation -Save lives
